The CDC’s Advisory Committee on Immunization Practices (ACIP) recently changed its recommendations for respiratory syncytial virus (RSV) vaccination suggesting that everyone ages 75 years and older receive the vaccine, but those 60 to 74 should be vaccinated only if they are at increased risk for severe RSV.
This recommendation replaces the previous guidance that called for shared clinical decision making for adults who are 60 and older to receive the vaccine.
“Under the